Elon Musk’s brain chip firm Neuralink says US regulators, the Food and Drug Administration (FDA) given approval for the implants to be tested on people. The company founded in 2016, sought approval from the FDA only in early 2022. The approval is a milestone in Neuralink's mission to enable direct communication between brains and computers.
The development was announced via a tweet by Neuralink, which was shared by Elon Musk.
“We are excited to share that we have received the FDA’s approval to launch our first-in-human clinical study! This is the result of incredible work by the Neuralink team in close collaboration with the FDA and represents an important first step that will one day allow our technology to help many people. Recruitment is not yet open for our clinical trial. We’ll announce more information on this soon!” Neuralink tweeted.
Neuralink, Musk had previously explained, Neuralink's implantable device would enable individuals to interact with computers using their minds.
The company's goal goes beyond medical applications, with aims to enhance human intellectual capabilities through brain-machine interfaces. The implantations have been tested on monkeys, where the animals were able to play video games using the Neuralink interface.